EX-99.C 3 c09527exv99wc.htm EXHIBIT C Exhibit C
Exhibit C
JOINT FILING STATEMENT
I, the undersigned, hereby express my agreement that the attached Schedule 13D (and any amendments thereto) relating to the Common Stock of Anacor Pharmaceuticals Inc. is filed on behalf of each of the undersigned.
Date: December 10, 2010
         
RHO VENTURES IV QP LP
RHO VENTURES IV LP
By   its General Partner, Rho Management
        Ventures IV LLC
 		    
By:   /s/ Jeffrey I. Martin      
  Jeffrey I. Martin     
  Authorized Signer     
 
RHO MANAGEMENT VENTURES IV LLC
 		    
By:   /s/ Jeffrey I. Martin      
  Jeffrey I. Martin     
  Authorized Signer     
 
RHO VENTURES IV GMBH & CO BETEILIGUNGS KG
By   its General Partner, Rho Capital Partners
        Verwaltungs GmbH
 		    
By:   /s/ Jeffrey I. Martin      
  Jeffrey I. Martin     
  Authorized Signer     
 
RHO CAPITAL PARTNERS VERWALTUNGS GMBH
 		    
By:   /s/ Jeffrey I. Martin      
  Jeffrey I. Martin     
  Authorized Signer     
 
RHO MANAGEMENT TRUST I
By   its Investment Advisor, Rho Capital Partners
        Inc.
 		    
By:   /s/ Jeffrey I. Martin      
  Jeffrey I. Martin     
  Authorized Signer     
 
RHO CAPITAL PARTNERS INC.
 		    
By:   /s/ Jeffrey I. Martin      
  Jeffrey I. Martin     
  Authorized Signer     
     
/s/ Jeffrey I. Martin      
Jeffrey I. Martin, as Authorized Signer, on behalf of Mark Leschly     
     
/s/ Jeffrey I. Martin      
Jeffrey I. Martin, as Authorized Signer, on behalf of Habib Kairouz     
     
/s/ Jeffrey I. Martin      
Jeffrey I. Martin, as Authorized Signer, on behalf of Joshua Ruch